We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+9.82%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+548.24%
AUM
$478B
AUM Growth
+$50B
Cap. Flow
+$13.3B
Cap. Flow %
2.79%
Top 10 Hldgs %
18.61%
Holding
4,322
New
132
Increased
3,091
Reduced
523
Closed
113

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$848M
2
BMY icon
Bristol-Myers Squibb
BMY
+$631M
3
TFC icon
Truist Financial
TFC
+$445M
4
AMZN icon
Amazon
AMZN
+$334M
5
NOW icon
ServiceNow
NOW
+$251M

Sector Composition

Rank Sector Weight
1 Technology 19.79%
2 Financials 15.45%
3 Healthcare 13.87%
4 Consumer Discretionary 9.9%
5 Industrials 9.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VXRT
4126
DELISTED
Vaxart
VXRT
$15K ﹤0.01%
44,729
BRN icon
4127
Barnwell Industries
BRN
$14.2M
$14K ﹤0.01%
14,145
MYO icon
4128
Myomo
MYO
$35.9M
$14K ﹤0.01%
1,612
TRIB
4129
Trinity Biotech
TRIB
$8.9M
$14K ﹤0.01%
93
INDP icon
4130
Indaptus Therapeutics
INDP
$243M
$13K ﹤0.01%
12
NTBL
4131
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
$13K ﹤0.01%
326
HUSN
4132
DELISTED
Hudson Capital Inc. Ordinary Shares
HUSN
$13K ﹤0.01%
5,274
VLRX
4133
DELISTED
VALERITAS HOLDINGS INC
VLRX
$12K ﹤0.01%
21,512
MNI
4134
DELISTED
The McClatchy Company Class A Common Stock
MNI
$12K ﹤0.01%
26,911
-6,715
-20% -$9.91K
TMBR
4135
DELISTED
Timber Pharmaceuticals, Inc.
TMBR
$11K ﹤0.01%
45
FTFT icon
4136
Future FinTech Group
FTFT
$1.74M
$10K ﹤0.01%
29
SSY
4137
DELISTED
SunLink Health Systems
SSY
$10K ﹤0.01%
10,217
TAOP icon
4138
Taoping
TAOP
$6.72M
$10K ﹤0.01%
11
YTEN
4139
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
$10K ﹤0.01%
62
STAB
4140
DELISTED
Statera Biopharma, Inc. Common Stock
STAB
$10K ﹤0.01%
17,598
TIO
4141
DELISTED
Tingo Group, Inc. Common Stock
TIO
$10K ﹤0.01%
11,589
ANY icon
4142
Sphere 3D
ANY
$15.7M
$9K ﹤0.01%
171
ATHE
4143
Alterity Therapeutics
ATHE
$80.5M
$9K ﹤0.01%
1,213
CREG
4144
DELISTED
Smart Powerr
CREG
$9K ﹤0.01%
32
GGE
4145
DELISTED
Green Giant Inc. Common Stock
GGE
$9K ﹤0.01%
6,970
IBIO icon
4146
iBio
IBIO
$67.6M
$8K ﹤0.01%
69
TOVX icon
4147
Theriva Biologics
TOVX
$10.1M
$8K ﹤0.01%
71
AEHL icon
4148
Antelope Enterprise Holdings
AEHL
$9.28M
$7K ﹤0.01%
2
BDRX
4149
Biodexa Pharmaceuticals
BDRX
$1.31M
0
ELDN icon
4150
Eledon Pharmaceuticals
ELDN
$255M
$7K ﹤0.01%
710

Similar funds

Geode Capital Management's Q4 2019 Portfolio in Review

As of Q4 2019, Geode Capital Management held 4,322 positions worth $478B, up 12% from $428B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Geode Capital Management's Q4 2019 filing shows 132 new, 3,091 increased, 523 reduced and 113 closed positions. Its largest new stake was Apollo Global Management: 1,482,213 shares worth $70.7M. The largest sale was Celgene Corp, an estimated $1.15B.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

  • Geode Capital Management's largest Q4 2019 buy was Apollo Global Management: 1,482,213 shares worth $70.7M.
  • Geode Capital Management added most to Microsoft in Q4 2019, an estimated $848M increase.
  • Geode Capital Management's biggest Q4 2019 reduction was Oracle, cutting an estimated $136M.
  • Geode Capital Management fully exited Celgene Corp in Q4 2019, selling an estimated $1.15B.
  • Geode Capital Management's ten largest holdings make up 19% of its $478B portfolio in Q4 2019.
  • Geode Capital Management opened 132 new positions and closed 113 in Q4 2019.
  • Geode Capital Management's portfolio value rose 12% quarter-over-quarter to $478B.

Based on Geode Capital Management's 13F filing for Q4 2019, filed 13 Feb 2020.